Published in Neuropathol Appl Neurobiol on July 07, 2016
Sequence and organization of the human mitochondrial genome. Nature (1981) 57.39
An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab (2001) 11.01
Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet (1998) 7.89
High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet (2006) 6.52
Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol (1984) 5.21
Prevalence of mitochondrial DNA disease in adults. Ann Neurol (2008) 4.72
Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet (2006) 4.61
A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science (2008) 3.95
Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol (1996) 3.89
SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet (1998) 3.79
Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry (1951) 3.58
CLARITY for mapping the nervous system. Nat Methods (2013) 3.20
Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain (2006) 3.16
Ubiquitin tag for sperm mitochondria. Nature (1999) 2.93
Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet (2004) 2.91
Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J Cereb Blood Flow Metab (2006) 2.86
Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci U S A (2007) 2.77
Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science (2013) 2.24
Hypoxia as a therapy for mitochondrial disease. Science (2016) 2.24
Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet (2005) 2.23
Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord (1992) 2.15
Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology (2004) 1.83
Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice. J Neurosci (2001) 1.81
MELAS associated with mutations in the POLG1 gene. Neurology (2007) 1.77
Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol (2015) 1.75
L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology (2005) 1.63
Complex I deficiency due to loss of Ndufs4 in the brain results in progressive encephalopathy resembling Leigh syndrome. Proc Natl Acad Sci U S A (2010) 1.62
Activity-driven local ATP synthesis is required for synaptic function. Cell (2014) 1.56
POLG mutations in Alpers syndrome. Neurology (2005) 1.49
Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming. Stem Cells (2011) 1.42
Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging. Neurology (1999) 1.31
Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol (2006) 1.29
Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet (2008) 1.29
Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model. Proc Natl Acad Sci U S A (2013) 1.28
Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology (2006) 1.27
Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology (2002) 1.27
Quality control: Genome maintenance in pluripotent stem cells. J Cell Biol (2014) 1.27
Mitochondrial diseases and epilepsy. Epilepsia (2012) 1.26
Mutations causing mitochondrial disease: What is new and what challenges remain? Science (2015) 1.24
Cerebral circulation in acute arterial hypertension--protective effects of sympathetic nervous activity. Acta Physiol Scand (1981) 1.24
Metabolic rescue in pluripotent cells from patients with mtDNA disease. Nature (2015) 1.23
MELAS and L-arginine therapy: pathophysiology of stroke-like episodes. Ann N Y Acad Sci (2010) 1.22
Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS. Stem Cells (2013) 1.22
Slowly progressive spread of the stroke-like lesions in MELAS. Neurology (2003) 1.21
Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann Neurol (2000) 1.20
Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease. FASEB J (2011) 1.19
Cerebellar ataxia in patients with mitochondrial DNA disease: a molecular clinicopathological study. J Neuropathol Exp Neurol (2012) 1.17
Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Ann Neurol (1991) 1.16
Nerve conduction abnormalities in patients with MELAS and the A3243G mutation. Arch Neurol (2006) 1.15
Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes. Brain (2010) 1.14
Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease. J Child Neurol (2009) 1.13
Mutation of the linker region of the polymerase gamma-1 (POLG1) gene associated with progressive external ophthalmoplegia and Parkinsonism. Arch Neurol (2007) 1.13
A defect in the mitochondrial complex III, but not complex IV, triggers early ROS-dependent damage in defined brain regions. Hum Mol Genet (2012) 1.13
Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease. Front Synaptic Neurosci (2010) 1.12
MFN2 mutations cause severe phenotypes in most patients with CMT2A. Neurology (2011) 1.11
MNGIE neuropathy: five cases mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve (2004) 1.09
Pathogenesis of stroke-like episodes in MELAS: analysis of neurovascular cellular mechanisms. Curr Neurovasc Res (2005) 1.04
Sensory neuronopathy in patients harbouring recessive polymerase γ mutations. Brain (2011) 1.03
Serial diffusion imaging in a case of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. Stroke (2008) 1.00
Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations. Brain (2013) 0.99
Effects of L-arginine on the acute phase of strokes in three patients with MELAS. Neurology (2002) 0.95
Age-associated mosaic respiratory chain deficiency causes trans-neuronal degeneration. Hum Mol Genet (2008) 0.95
Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease. Neuropathol Appl Neurobiol (2015) 0.95
Peripheral neuropathy in patients with the 3243A>G mutation in mitochondrial DNA. J Neurol (2003) 0.94
Serial diffusion-weighted imaging in MELAS. Neuroradiology (2000) 0.94
Characterizing POLG ataxia: clinics, electrophysiology and imaging. Cerebellum (2012) 0.94
Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders. Brain (2013) 0.92
Epileptic phenotypes associated with mitochondrial disorders. Neurology (2001) 0.92
Vascular involvement in mitochondrial myopathy. Ann Neurol (1989) 0.91
Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome. Brain (2003) 0.91
Serial brain imaging analysis of stroke-like episodes in MELAS. Brain Dev (2008) 0.90
MELAS with the mitochondrial DNA 3243 point mutation: a neuropathological study. Acta Neuropathol (2000) 0.89
Posterior reversible encephalopathy syndrome in an adult patient undergoing peritoneal dialysis: a case report and literature review. BMC Nephrol (2014) 0.88
Mitochondrial encephalomyopathy with lactic acidosis and stroke like episodes (MELAS) with prominent degeneration of the intestinal wall and cactus-like cerebellar pathology. Acta Neuropathol (2000) 0.88
Adult-onset MELAS. Evidence for involvement of neurons as well as cerebral vasculature in strokelike episodes. Stroke (1996) 0.88
Quantitative quadruple-label immunofluorescence of mitochondrial and cytoplasmic proteins in single neurons from human midbrain tissue. J Neurosci Methods (2014) 0.87
Neuropathologic features of pontocerebellar hypoplasia type 6. J Neuropathol Exp Neurol (2014) 0.87
Neuroimaging characteristics in mitochondrial encephalopathies associated with the m.3243A>G MTTL1 mutation. J Neurol (2012) 0.87
Predominant cerebellar volume loss as a neuroradiologic feature of pediatric respiratory chain defects. AJNR Am J Neuroradiol (2005) 0.87
The A8344G mutation in mitochondrial DNA associated with stroke-like episodes and gastrointestinal dysfunction. Acta Neuropathol (2002) 0.85
Epileptic phenotypes in children with respiratory chain disorders. Epilepsia (2010) 0.85
Partial complex I deficiency due to the CNS conditional ablation of Ndufa5 results in a mild chronic encephalopathy but no increase in oxidative damage. Hum Mol Genet (2013) 0.85
Relationship between mitochondria and α-synuclein: a study of single substantia nigra neurons. Arch Neurol (2012) 0.85
MELAS: clinical phenotype and morphological brain abnormalities. Acta Neuropathol (2003) 0.85
Disconnection of cerebellar Purkinje cells in Kearns-Sayre syndrome. J Neurol Sci (1999) 0.84
Serial diffusion-weighted imaging in a patient with MELAS and presumed cytotoxic oedema. Neuroradiology (2003) 0.84
Microangiopathy in the cerebellum of patients with mitochondrial DNA disease. Brain (2012) 0.83
Inappropriate intracranial hemodynamics in the natural course of MELAS. Brain Dev (2007) 0.82
The neuropsychologic deficits of MELAS: evidence of global impairment. Cogn Behav Neurol (2007) 0.82
Loss of myelin-associated glycoprotein in kearns-sayre syndrome. Arch Neurol (2012) 0.81
Decreased hippocampal expression of calbindin D28K and cognitive impairment in MELAS. J Neurol Sci (2012) 0.80
Investigating complex I deficiency in Purkinje cells and synapses in patients with mitochondrial disease. Neuropathol Appl Neurobiol (2015) 0.80
Focal cognitive impairment in mitochondrial encephalomyopathies: a neuropsychological and neuroimaging study. J Neurol Sci (1999) 0.80
Clinicopathological aspects of the neuropathy of neurogastrointestinal encephalomyopathy (MNGIE) in four patients including two with a Charcot-Marie-Tooth presentation. J Neurol (2005) 0.80
Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function. Mitochondrion (2015) 0.80
Epilepsy in adults with mitochondrial disease: A cohort study. Ann Neurol (2015) 0.80
Recurrent Stroke-Like Episodes in FBXL4-Associated Early-Onset Mitochondrial Encephalomyopathy. Pediatr Neurol (2015) 0.80
Mitochondrial DNA homeostasis is essential for nigrostriatal integrity. Mitochondrion (2016) 0.79
Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies. Mitochondrion (2015) 0.79